Nakamura Toshitaka

Inhibition of Bone Resorption by Pamidronate Cannot Restore Normal Gain in Cortical Bone Mass and Strength in Tail-Suspended Rapidly Growing Rats

Yoshiaki Kodama, Konosuke Nakayama, Hiroaki Fuse et al. · Journal of Bone and Mineral Research · 1997 · 76 citations · Full text

An Allopurinol-Controlled, Multicenter, Randomized, Open-Label, Parallel Between-Group, Comparative Study of Febuxostat (TMX-67), a Non-Purine-Selective Inhibitor of Xanthine Oxidase, in Patients With Hyperuricemia Including Those With Gout in Japan

Naoyuki Kamatani, Shin Fujimori, Toshikazu Hada et al. · JCR Journal of Clinical Rheumatology · 2011 · 50 citations

The efficacy of alendronate in reducing the risk for vertebral fracture in japanese patients with osteoporosis: A randomized, double-blind, active-controlled, double-dummy trial

Kazuhiro Kushida, Masataka Shiraki, Nakamura Toshitaka et al. · Current Therapeutic Research · 2002 · 47 citations

Bone Disease, Vertebral Fracture, Bone Health +4

Placebo-Controlled Double-Blind Dose-Response Study of the Non-Purine-Selective Xanthine Oxidase Inhibitor Febuxostat (TMX-67) in Patients With Hyperuricemia (Including Gout Patients) in Japan

Naoyuki Kamatani, Shin Fujimori, Toshikazu Hada et al. · JCR Journal of Clinical Rheumatology · 2011 · 35 citations

Placebo-Controlled, Double-Blind Study of the Non-Purine-Selective Xanthine Oxidase Inhibitor Febuxostat (TMX-67) in Patients With Hyperuricemia Including Those With Gout in Japan

Naoyuki Kamatani, Shin Fujimori, Toshikazu Hada et al. · JCR Journal of Clinical Rheumatology · 2011 · 31 citations